InvestorsHub Logo
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

Re: None

Thursday, 07/24/2014 7:45:24 AM

Thursday, July 24, 2014 7:45:24 AM

Post# of 80490
There may be a recognition in the biotech investing community that Yellen's dis of biotechs was way off base, that she is completely out of her depth in this area and that the sell-off that she caused was not justified. In fact the truth may be that biotechs are way undervalued.

http://www.investorvillage.com/smbd.asp?mb=16353&mn=7151&pt=msg&mid=14022448

George Scanos on CNBC....""This is an amazing period that we are in right now in that the science and the medicine are advancing so quickly - look good drugs come from understanding of biology - so its really an understanding of the disease mechanisms that are important .....allows targeting of therapies today at a higher degree of success"

Buyouts are going to accelerate. Don't minimize the Bellicum news. Everyone wants a foot in on CAR-T. Ariad owns 10% of Bellicum.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.